Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | CHRNB2 | P17787 | 6/20 | 0.52 |
| ▸ | CHRNA4 | P43681 | 6/20 | 0.52 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.52 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.52 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.52 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.52 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | CHRNB4 | P30926 | 3/20 | 0.40 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14999214 | 0.92 | TSHR (0.56) | THRBCHRNB2CHRNA4CHRM2CHRM4 | |
| SCHEMBL14999290 | 0.89 | CHRNB2 (0.55) | THRBCHRNB2CHRNA4CHRM2CHRM4 | |
| Trimethylammonium SCHEMBL28556159 | 0.87 | THRB (0.65) | THRBCHRNB2CHRNA4CHRM2CHRM4 | |
| SCHEMBL15636 | 0.84 | THRB (0.74) | THRBCHRNB2CHRNA4CHRM2CHRM4 | |
| SCHEMBL6142874 | 0.84 | THRB (0.74) | THRBCHRNB2CHRNA4CHRM2CHRM4 | |
| Ethylene SCHEMBL9485953 | 0.82 | THRB (0.71) | THRBCHRNB2CHRNA4CHRM2CHRM4 | |
| Ethylene SCHEMBL2367613 | 0.82 | THRB (0.71) | THRBCHRNB2CHRNA4CHRM2CHRM4 | |
| Ethylene SCHEMBL9301341 | 0.82 | THRB (0.71) | THRBCHRNB2CHRNA4CHRM2CHRM4 | |
| SCHEMBL3286289 | 0.82 | THRB (0.71) | THRBCHRNB2CHRNA4CHRM2CHRM4 | |
| Ethylene SCHEMBL8506065 | 0.82 | THRB (0.71) | THRBCHRNB2CHRNA4CHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9212132-B2 | (Meth)acrylic acid ester, activation energy ray curing composition, and inkjet recording ink | RICOH COMPANY LTD. (JP) | 2015-12-15 | — | — | US | disclosed |
| US-9212132-B2 | (Meth)acrylic acid ester, activation energy ray curing composition, and inkjet recording ink | RICOH COMPANY LTD. (JP) | 2015-12-15 | — | — | US | disclosed |
| EP-2602244-A1 | (Meth) Acrylic acid ester, activation energy ray curing composition, and inkjet recording ink | Ricoh Company, Ltd. (JP) | 2013-06-12 | — | — | EP | disclosed |
| US-20130144057-A1 | (METH)ACRYLIC ACID ESTER, ACTIVATION ENERGY RAY CURING COMPOSITION, AND INKJET RECORDING INK | RICOH COMPANY, LTD. (JP) | 2013-06-06 | — | — | US | disclosed |
| US-20130144057-A1 | (METH)ACRYLIC ACID ESTER, ACTIVATION ENERGY RAY CURING COMPOSITION, AND INKJET RECORDING INK | RICOH COMPANY, LTD. (JP) | 2013-06-06 | — | — | US | disclosed |
| US-20080003288-A1 | Responsive microgel and methods related thereto | SUPRATEK PHARMA INC. (CA) | 2008-01-03 | — | — | US | disclosed |
| US-7204997-B2 | Responsive microgel and methods related thereto | SUPRATEK PHARMA INC. (CA) | 2007-04-17 | — | — | US | disclosed |
| EP-1478403-A1 | RESPONSIVE MICROGEL AND METHODS RELATED THERETO | SUPRATEK PHARMA, INC. (CA) | 2004-11-24 | — | — | EP | disclosed |
| US-20030152623-A1 | Responsive microgel and methods related thereto | SUPRATEK PHARMA INC. (CA) | 2003-08-14 | — | — | US | disclosed |
| WO-2003063909-A1 | RESPONSIVE MICROGEL AND METHODS RELATED THERETO | SUPRATEK PHARMA INC. (US) | 2003-08-07 | — | — | WO | disclosed |
| EP-0907666-A1 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. Searle & Co. (US) | 1999-04-14 | — | — | EP | disclosed |
| WO-1997049736-A2 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. SEARLE AND CO. (US) | 1997-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130144057-A1 | (METH)ACRYLIC ACID ESTER, ACTIVATION ENERGY RAY CURING COMPOSITION, AND INKJET RECORDING INK | MNAT1, MLLT1, METTL3 | THRB 3526/4885CHRNB2 2724/4885CHRNA4 2666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.